Keyphrases
Liver Transplantation
100%
Hepatocellular Carcinoma
30%
Orthotopic Liver Transplantation
27%
Graft Survival
22%
Liver
22%
Transplantation
21%
Split Liver Transplantation
20%
Flow Cytometry Crossmatch
20%
Atorvastatin
20%
Survival Prediction
20%
MELD Score
20%
Patient Survival
17%
Cyclosporine
15%
Recurrent Disease
15%
Early Graft Failure
15%
Hepatitis B
15%
Liver Transplant Recipients
14%
Renal Function
14%
Calcineurin Inhibitors
14%
Natural Killer Cells
14%
Patient Outcomes
13%
Rejection Rate
12%
Actuarial Survival
12%
Pretransplant
11%
Immunosuppressive Agents
11%
Reductase Inhibitors
11%
Renal Transplant Recipients
11%
Hospital Stay
11%
Lamivudine
10%
Polycystic Liver Disease
10%
Recurrent Hepatitis
10%
Surgical Palliation
10%
Hepatocellular Carcinoma Recurrence
10%
Surgical Transplantation
10%
Factors Affecting Outcome
10%
Sirolimus
10%
Estimated Glomerular Filtration Rate
10%
ICU Stay
10%
Right Hepatic Vein
10%
Donor Demographics
10%
Marginal Donor
10%
Adult Liver Transplantation
10%
Clinical Dimensions
10%
Right Lobe
10%
Outflow Reconstruction
10%
Hepatic Venous Outflow
10%
Middle Hepatic Vein
10%
Renal Outcome
10%
Grafting Ratio
10%
Primary Liver Transplantation
10%
Medicine and Dentistry
Liver Transplantation
90%
Liver Graft
37%
Hepatocellular Carcinoma
30%
Kidney Graft
22%
Recurrent Disease
21%
Graft Survival
16%
Graft Failure
16%
Kidney Function
14%
Cyclosporine
14%
Living Donor
14%
Liver Function
12%
Retransplantation
12%
Tacrolimus
11%
Pediatrics
10%
Immunosuppressive Treatment
10%
Rapamycin
10%
Calcineurin Inhibitor
10%
Nephrotoxicity
10%
Immunosuppressive Drug
10%
Oxidoreductase
10%
Pravastatin
10%
Model For End Stage Liver Disease Score
10%
Hepatitis B
10%
Vein Blood Flow
10%
Hyperlipidemia
10%
Cost-Effectiveness Analysis
10%
Kidney Transplantation
10%
Liver Polycystic Disease
10%
Hepatitis B Antibody
10%
Coenzyme A
10%
Hepatic Vein
10%
Lamivudine
10%
Polycystic Kidney Disease
10%
Monotherapy
10%
Hepatitis C
10%
Symptomatic Treatment
10%
Radiofrequency Ablation
10%
Translational Research
10%
Immunology
10%
Hepatitis B Virus
9%
Hepatitis C Virus
8%
Ataxia
7%
Diseases
7%
Neoplasm
7%
Mycophenolate Mofetil
6%
Tumor Necrosis
6%
Eosin
6%
Haematoxylin
6%
Necrosis
6%
High Risk Population
5%
